» Articles » PMID: 26742647

17beta-estradiol Counteracts Neuropathic Pain: a Behavioural, Immunohistochemical, and Proteomic Investigation on Sex-related Differences in Mice

Overview
Journal Sci Rep
Specialty Science
Date 2016 Jan 9
PMID 26742647
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Sex differences play a role in pain sensitivity, efficacy of analgesic drugs and prevalence of neuropathic pain, even if the underlying mechanisms are far from being understood. We demonstrate that male and female mice react differently to structural and functional changes induced by sciatic nerve ligature, used as model of neuropathic pain. Male mice show a gradual decrease of allodynia and a complete recovery while, in females, allodynia and gliosis are still present four months after neuropathy induction. Administration of 17β-estradiol is able to significantly attenuate this difference, reducing allodynia and inducing a complete recovery also in female mice. Parallel to pain attenuation, 17β-estradiol treated-mice show a functional improvement of the injured limb, a faster regenerative process of the peripheral nerve and a decreased neuropathy-induced gliosis. These results indicate beneficial effects of 17β-estradiol on neuropathic pain and neuronal regeneration and focuses on the importance of considering gonadal hormones also in clinical studies.

Citing Articles

Influencing factors and repair advancements in rodent models of peripheral nerve regeneration.

Olsen T, LaGuardia J, Chen D, Lebens R, Huang K, Milek D Regen Med. 2024; 19(11):561-577.

PMID: 39469920 PMC: 11633413. DOI: 10.1080/17460751.2024.2405318.


Comparison of pain modulatory effect of the LPGi estragon receptor on inflammatory pain between pro-estrus and estrus phases and OVX rats.

Ansari S, Khahpay R, Khakpai F, Heidarzadeh Z, Khojasteh S Psychopharmacology (Berl). 2024; 242(1):129-147.

PMID: 39180591 DOI: 10.1007/s00213-024-06653-2.


Pathology of pain and its implications for therapeutic interventions.

Cao B, Xu Q, Shi Y, Zhao R, Li H, Zheng J Signal Transduct Target Ther. 2024; 9(1):155.

PMID: 38851750 PMC: 11162504. DOI: 10.1038/s41392-024-01845-w.


Pain mechanisms in the transgender individual: a review.

Anger J, Case L, Baranowski A, Berger A, Craft R, Damitz L Front Pain Res (Lausanne). 2024; 5:1241015.

PMID: 38601924 PMC: 11004280. DOI: 10.3389/fpain.2024.1241015.


TNFR1/p38αMAPK signaling in Nex + supraspinal neurons regulates estrogen-dependent chronic neuropathic pain.

Swanson K, Nguyen K, Gupta S, Ricard J, Bethea J Brain Behav Immun. 2024; 119:261-271.

PMID: 38570102 PMC: 11162907. DOI: 10.1016/j.bbi.2024.03.050.


References
1.
Caprioli A, Coccurello R, Rapino C, Di Serio S, Di Tommaso M, Vertechy M . The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models. J Pharmacol Exp Ther. 2012; 342(1):188-95. DOI: 10.1124/jpet.111.191403. View

2.
Sanoja R, Cervero F . Estrogen modulation of ovariectomy-induced hyperalgesia in adult mice. Eur J Pain. 2007; 12(5):573-81. DOI: 10.1016/j.ejpain.2007.09.003. View

3.
Draisci G, Catarci S, Vollono C, Zanfini B, Pazzaglia C, Cadeddu C . Pregnancy-induced analgesia: a combined psychophysical and neurophysiological study. Eur J Pain. 2012; 16(10):1389-97. DOI: 10.1002/j.1532-2149.2012.00139.x. View

4.
Gintzler A, Liu N . Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors. Front Neuroendocrinol. 2012; 33(4):412-24. PMC: 3778676. DOI: 10.1016/j.yfrne.2012.09.004. View

5.
Cui J, Shen Y, Li R . Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 2013; 19(3):197-209. PMC: 3595330. DOI: 10.1016/j.molmed.2012.12.007. View